Gufic Biosciences to grab a major share of Rs. 3,000 crore lyophilized antibacterial market
The company has launched indigenously produced Dual Chamber Bags of global standards in India at a pocket-friendly price
The company has launched indigenously produced Dual Chamber Bags of global standards in India at a pocket-friendly price
The new Oncology CRO will aim to drive faster execution and higher quality trial outcomes for Oncology sponsors.
Govt. has set a target to increase the number of JanAushadhi Kendras to 10,000 by March 2024
Trial will assess safety and antibody responses of NVX-CoV2515 to the Omicron variant of COVID-19
Bempedoic acid helps lower cardiovascular risk in high or very high-risk atherosclerotic cardiovascular disease (ASCVD) patients as an add-on therapy to maximally tolerated statin and/or ezetimibe
The company has posted net profit of Rs.884.08 crores for the Financial Year ended March 31, 2022.
The study was conducted in equal laboratory conditions in the Spallanzani Institute in Italy on comparable sera samples from individuals vaccinated with Sputnik V and Pfizer with a similar level of IgG antibodies and virus-neutralizing activity (VNA) against Wuhan variant.
The hybrid congress will take place from 1-4 June in Copenhagen, as well as virtually
The two companies will work together for the Prospective Evaluation of OrionAI – a revolutionary AI-based Diagnostic Assistant for Histological Examination of a variety of solid tumours beginning with Head and Neck Squamous Cell Carcinoma (HNSCC) Cancer
The technology was able to identify approximately 32 percent more adenomas than standard colonoscopy procedures
Subscribe To Our Newsletter & Stay Updated